Bleomycin inhibits CLEC14A to attenuate the progression of extracranial arteriovenous malformations

Fleetwood, 2002, Arteriovenous malformations, Lancet, 359, 863, 10.1016/S0140-6736(02)07946-1 Kohout, 1998, Arteriovenous malformations of the head and neck: natural history and management, Plast Reconstr Surg, 102, 643, 10.1097/00006534-199809010-00006 Jin, 2018, Treatment of early-stage extracranial arteriovenous malformations with intralesional interstitial bleomycin injection: a pilot study, Radiology, 287, 194, 10.1148/radiol.2017162076 Horbach, 2016, Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis, Plast Reconstr Surg, 137, 244, 10.1097/PRS.0000000000001924 Rho, 2011, Clec14a is specifically expressed in endothelial cells and mediates cell to cell adhesion, Biochem Biophys Res Commun, 404, 103, 10.1016/j.bbrc.2010.11.075 Noy, 2015, Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth, Oncogene, 34, 5821, 10.1038/onc.2015.34 Lee, 2017, Carbohydrate-binding protein CLEC14A regulates VEGFR-2- and VEGFR-3-dependent signals during angiogenesis and lymphangiogenesis, J Clin Invest, 127, 457, 10.1172/JCI85145 Baeyens, 2016, Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia, J Cell Biol, 214, 807, 10.1083/jcb.201603106 Tu, 2014, Notch 1 and 4 signaling responds to an increasing vascular wall shear stress in a rat model of arteriovenous malformations, BioMed Res Int, 2014, 368082, 10.1155/2014/368082 Galie, 2014, Fluid shear stress threshold regulates angiogenic sprouting, Proc Natl Acad Sci U S A, 111, 7968, 10.1073/pnas.1310842111 Bocci, 2019, Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer, Angiogenesis, 22, 117, 10.1007/s10456-018-9642-5 Zanivan, 2013, SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers, Mol Cell Proteomics, 12, 3599, 10.1074/mcp.M113.031344